To clarify the sequential events in the glomeruli after exposure of FSGS plasma in situ, we analyzed the molecular change of podocytes in transplanted kidney. Methods: Five sets of renal graft specimens were studied in three time frames, before reperfusion (0 hour), one hour after reperfusion(1 hour), and several days after reperfusion(episode). FSGS recurred in three of all five cases after transplant, with massive proteinuria within 72

hours from reperfusion. We analyzed the degree of foot process (FP) effacement, intracellular localization of various functional proteins of podocytes by confocal microscopy, and podocyte number in glomeruli through these periods of time. Results: Within one hour after reperfusion, FP effacement was observed only in all the three post-transplant recurrent cases. Staining pattern of Neph1, SIRP alpha, Zo-1, Podocalyxin, see more Ezrin, Synaptopodin, Vimentin did not change in any specimens of all cases. However, in all the recurrent cases, staining pattern of Nephrin and Podocin altered from linear pattern to granular pattern in cytoplasm as early as one hour after reperfusion. These cytoplasmic Podocin and Nephrin were partially localized in Golgi apparatus, but not in ER. Coarse granular staining of CD2AP, which is https://www.selleckchem.com/products/BKM-120.html distinct from that of Nephrin or Podocin, was also observed in 1 hour and later specimen only in recurrent cases. Podocyte number did not change during the study period. Conclusion: Exposure to recurrent

FSGS sera for one hour results in dissociation and partial translocation of slit diaphragm component to cytoplasm and simultaneous FP effacement. These hyperacute changes which precede proteinuria represent fundamental mechanism which underlie the pathogenesis of FSGS, and may hold predictive value in FSGS recurrurence. MUTO SATORU1,10, MOCHIZUKI TOSHIO2, TSUCHIYA KEN2,

NISHIO SAORI3, HANAOKA KAZUSHIGE4, TSURUYA KAZUHIKO5, ISHIMURA EIJI6, KAMURA KOU-ICHI7, Gemcitabine clinical trial NARITA ICHIEI8, NUTAHARA KIKUO9, HORIE SHIGEO10 1Dept. of Urology, Teikyo University; 2Dept. of Nephrology, Tokyo Woman’s Medical University; 3The 2nd Dept. of Internal Medicine, Hokkaido University; 4Dept. of Nephrology, Jikei University School of Medicine; 5Dept. of Medicine and Clinical Science, Kyushu University; 6Dept. of Nephrology, Osaka City University School of Medicine; 7Dept. of Urology, Chiba East Hospital; 8The 2nd Dept. of Internal Medicine, Niigata University; 9Dept. of Urology, Kyorin University; 10Dept. of Urology, Juntendo University Introduction: The PKD Sectional Committee of a Grant-in-Aid for Progressive Renal Diseases Research, from the Ministry of Health, Labour and Welfare of Japan established the first nationwide, web-based, and prospective registry system, the Japan PKD Registry (J-PKD), to record clinical, and laboratory data about PKD in Japan. Although the follow-up periods of this study were 5 years, we will report the compiling data at the time of enrollment in J-PKD registry.